Review Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Sign: In combination with chemotherapy, for your therapy of adult clients with locally recurrent unresectable or metastatic triple-damaging breast most cancers who've not obtained prior chemotherapy for metastatic sickness and whose tumours express programmed mobile Dying-ligand one (